Hilary Coon | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Research Excellence Award

Hilary Coon
University of Utah School of Medicine

Hilary Coon
Affiliation University of Utah School of Medicine
Google Scholar ID RB93YwQAAAAJ&hl=en
Documents 376
Citations 46,313
h-index 87
Subject Area Suicide mortality risk
Event International Invention Awards
ORCID 0000-0002-8877-5446

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Abstract

Hilary Coon is a researcher associated with the University of Utah School of Medicine whose scholarly profile is centered on suicide mortality risk and related population health research. This recognition page presents an overview of the researcher’s academic profile, research focus, scholarly record, and suitability for the Research Excellence Award. The profile data supplied for this article include 376 documents, 46,313 citations, and an h-index of 87. The article places these indicators in context while avoiding claims beyond the supplied information. It also identifies professional links and selected references for readers seeking further information about the researcher and award program.

Keywords

Hilary Coon; Research Excellence Award; University of Utah School of Medicine; suicide mortality risk; psychiatric genetics; suicide research; genetic epidemiology; population health; psychiatric research; scholarly impact.

Introduction

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Research Profile

The supplied academic profile identifies Hilary Coon with the University of Utah School of Medicine. Her stated subject area is suicide mortality risk. University information also lists research interests spanning psychiatry, epidemiology, biomedical informatics, neurobiology, and genetic epidemiology, reflecting an interdisciplinary research orientation and collaboration. [1]

Research Contributions

Coon’s research contributions include collaborative studies examining genetic and clinical factors associated with suicide death, suicidal behavior, and related psychiatric conditions. Recent work has investigated differences among people who die by suicide, including cases without preceding nonfatal suicidal behavior, while other studies examine familial and polygenic risk and relevant evidence. [1] [2]

Publications

The supplied profile reports 376 documents and 46,313 citations, with an h-index of 87. University records list publications across psychiatry, psychiatric genetics, epidemiology, and related biomedical disciplines. Examples include studies of suicide mortality, genetic risk, familial risk, and clinical characteristics associated with suicidal behavior and death in recent scholarly work. [1]

Research Impact

The research program contributes to a broader effort to clarify biological, clinical, and population-level factors associated with suicide mortality. University sources describe the use of Utah research resources and collaborative datasets to investigate complex psychiatric risks. Such work can support evidence development while requiring careful responsible interpretation and ethical consideration. [1]

Award Suitability

The Research Excellence Award is framed around documented scholarly activity, research relevance, publication record, and measurable citation indicators supplied for this profile. Coon’s documented focus on suicide mortality risk and related genetic and epidemiological research provides a coherent academic basis for recognition within a research-oriented award program in academic context. [1]

Conclusion

Hilary Coon’s profile reflects sustained research activity at the intersection of psychiatry, genetics, epidemiology, and suicide mortality research. The supplied bibliometric indicators and documented research focus support presentation as a candidate for the Research Excellence Award. Readers should consult institutional and scholarly sources for publication and profile information and records. [1] [2]

References

  1. ORCID. (n.d.). Hilary Coon, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0002-8877-5446
  2. Coon, H., Shabalin, A. A., DiBlasi, E., et al. (2025). Understanding heterogeneity in suicidal thoughts and behaviours and the implications for genetic studies – a commentary on Lannoy et al. (2022).
    https://doi.org/10.1111/jcpp.13778
  3. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

 

Tahir Turk | Health Professions | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Tahir Turk
Dow University of Health Sciences, Australia

Tahir Turk
Affiliation Dow University of Health Sciences
Country Australia
Scopus ID 37091848000
Documents 20
Citations 278
h-index 9
Subject Area Health Professions
Event International Invention Awards
ORCID 0000-0002-8119-4171

Tahir Turk is a researcher associated with Dow University of Health Sciences whose scholarly activities focus on public health, health promotion, nutrition-sensitive social protection, social and behaviour change communication (SBCC), and water, sanitation and hygiene initiatives. His publication record demonstrates engagement with evidence-based interventions designed to improve health outcomes in diverse communities and low- and middle-income country settings. Through interdisciplinary collaborations, his work contributes to the understanding of behavioural determinants of health and the development of context-specific communication strategies.[1]

Abstract

This article reviews the academic profile of Tahir Turk and highlights contributions to public health research, nutrition-sensitive interventions, behavioural communication strategies, and WASH-related initiatives. His publications demonstrate a commitment to co-design methodologies, systematic evidence synthesis, and community-centered health promotion. The body of work reflects practical applications of behavioural science within public health programs and supports the advancement of effective communication frameworks for improving population health outcomes.[2]

Keywords

Public Health, Health Promotion, Social and Behaviour Change Communication, Nutrition, WASH, Community Engagement, Co-design Research, Systematic Review.

Introduction

Modern public health challenges increasingly require integrated approaches that combine behavioural science, community participation, and evidence-informed interventions. Tahir Turk’s research addresses these priorities through studies examining nutrition-sensitive social protection programs, obesity prevention strategies, and sanitation-related behavioural change initiatives. His work contributes to contemporary discussions regarding the implementation and evaluation of public health communication programs.[3]

Research Profile

According to available scholarly metrics, Tahir Turk has authored twenty indexed publications, accumulating 278 citations and an h-index of 9. His primary subject classification falls within Health Professions, with interdisciplinary engagement across public health, nutrition, health communication, and implementation research. The research portfolio demonstrates sustained attention to improving health outcomes through participatory and culturally informed intervention models.[1]

Research Contributions

  • Development of co-designed WASH communication strategies in Kiribati.
  • Systematic review of social and behaviour change communication interventions within nutrition-sensitive social protection programs.
  • Integration of co-design methodologies into formative research frameworks for low- and middle-income countries.
  • Research supporting obesity prevention communication strategies in Pacific Island contexts.

Publications

  • Co-designing water sanitation and hygiene (WASH) messages for a social and behaviour change campaign in Kiribati (2026).
  • Effect of Integrating Social and Behavior Change Communication Strategies in Nutrition-Sensitive Social-Protection Programs on Specific Nutritional Outcomes: A Systematic Review (2026).
  • Integrating co-design into formative research for a SBCC entry-point platform for nutrition-sensitive social protection programs (2025).
  • Conducting formative research during a pandemic threat to inform obesity prevention communication strategies in Tonga (2024).

Research Impact

The impact of Turk’s scholarship is reflected in its emphasis on practical implementation and community engagement. His studies support policymakers, public health practitioners, and development organizations seeking evidence-based approaches to behavioural change and nutrition improvement. The combination of systematic reviews, formative research, and co-design methods strengthens the applicability of findings across diverse health settings.[4]

Award Suitability

Tahir Turk’s contributions align with the objectives of the International Invention Awards by demonstrating innovation in health communication, participatory research design, and public health intervention development. The integration of behavioural science principles into real-world health programs illustrates scholarly originality and practical relevance. His research record provides evidence of sustained academic productivity and measurable scholarly influence within the field of health professions.[5]

Conclusion

The academic profile of Tahir Turk highlights a focused commitment to advancing public health through behavioural communication research, nutrition-sensitive programming, and participatory intervention design. His body of work contributes valuable insights for researchers and practitioners working to improve health outcomes through evidence-based and community-centered approaches.

References

  1. Elsevier. (n.d.). Scopus author details: Tahir Turk, Author ID 37091848000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37091848000
  2. Public Health in Practice. (2026). Co-designing water sanitation and hygiene (WASH) messages for a social and behaviour change campaign in Kiribati.
    DOI: https://doi.org/10.1016/j.puhip.2026.100821
  3. Nutrition Reviews. (2026). Effect of Integrating Social and Behavior Change Communication Strategies in Nutrition-Sensitive Social-Protection Programs on Specific Nutritional Outcomes.
    DOI: https://doi.org/10.1093/nutrit/nuaf063
  4. PLOS One. (2025). Integrating co-design into formative research for a SBCC entry-point platform.
    DOI: https://doi.org/10.1371/journal.pone.0310288
  5. Health Promotion Journal of Australia. (2024). Conducting formative research during a pandemic threat to inform the development of an obesity prevention strategy in Tonga.
    DOI: https://doi.org/10.1002/hpja.821
  6. medRxiv Preprint. (2024). Integrating co-design into formative research for nutrition-sensitive social protection programs.
    DOI: https://doi.org/10.1101/2024.09.08.24313037

Ana Maria Mihai | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 26242

Register Here

 

Vraj Rangrej | Internal Medicine | Young Researcher Award

Published on by Invention Awards
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 26049

Register Here

 

Gabriella Teresa Capolupo | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards

Dr. Gabriella Teresa Capolupo | Medicine and Dentistry | Excellence in Research Award

Dr. Gabriella Teresa Capolupo | Università campus bio medico di Roma | Italy

Gabriella Teresa Capolupo is an accomplished surgeon, researcher, and academic with extensive expertise in general, oncological, and digestive surgery. She has built a distinguished career that integrates advanced clinical practice with dedicated teaching and scientific contributions. As a university lecturer and instructor, she actively contributes to academic programs in General Surgery, Urology, Digestive Surgery, Endocrinology and Metabolic Surgery, Emergency Surgery, and Head and Neck Surgery. Her educational roles include formal teaching, clinical tutoring, multidisciplinary course integration, and participation in advanced training initiatives such as postgraduate master programs and summer schools. She also serves as coordinator of the tutoring activities for the School of Specialization in General Surgery, ensuring high-quality mentorship for surgical trainees and supporting their academic and clinical progression. Her academic profile is further strengthened by appointments to evaluation bodies, including doctoral examination committees in translational medicine and oncology. Clinically, Dr. Capolupo’s work is rooted in continuous service at a major university hospital, where she has operated within colorectal, general, and geriatric surgery units. She performs a broad range of surgical procedures with recognized expertise in abdominal oncological surgery using both laparotomic and laparoscopic approaches. Her responsibilities include acting as first surgeon, surgical assistant, and tutor in the operating room, as well as leading emergency surgical teams. She has held roles with functional leadership responsibilities across both permanent and fixed-term appointments. Her research activity is substantial and internationally recognized, with 2,050 citations, 105 scientific documents, and an h-index of 19, reflecting her influence and scholarly impact in the field of surgical sciences. Dr. Capolupo’s professional trajectory demonstrates a strong and consistent commitment to clinical excellence, scientific advancement, and the training of future medical professionals.

Profiles: Scopus | Orcid

Featured Publications

Schiavone, V., Carannante, F., Melone, G., Miacci, V., Costa, G., Taffon, C., Caricato, M., Capolupo, G. T., & Mascianà, G. (2025). Tailoring the management of colonic lipomas: A 10-year experience of surgical and endoscopic resection. Journal of Personalized Medicine, 15(11), 544. https://doi.org/10.3390/jpm15110544

Schiavone, V., Capolupo, G. T., Mascianà, G., Carannante, F., Costa, G., Miacci, V., & Caricato, M. (2025). Non-operative management (NOM) in rectal cancer: Current evidence and future directions. Encyclopedia, 5(4), 165. https://doi.org/10.3390/encyclopedia5040165

Carannante, F., Capolupo, G. T., Barberio, M., Altamura, A., Miacci, V., Scopigno, M. Z., Circhetta, E., Costa, G., Caricato, M., & Viola, M. G. (2024). Evaluation of short-term effects on colorectal surgery elective patients after implementing a patient blood management program: A multicenter retrospective analysis. Journal of Clinical Medicine, 13(15), 4447. https://doi.org/10.3390/jcm13154447

Feola, A., Minotti, C., Marchetti, D., Caricato, M., Capolupo, G. T., Marsella, L. T., & La Monaca, G. (2021). A five-year survey for plastic surgery malpractice claims in Rome, Italy. Medicina, 57(6), 571. https://doi.org/10.3390/medicina57060571

Mascianà, G., Capolupo, G. T., Carannante, F., & Caricato, M. (2019). An omental mass. Any idea? International Journal of Surgery Case Reports, 57, 161–164. https://doi.org/10.1016/j.ijscr.2019.02.019

Catarci, M., Ruffo, G., Borghi, F., Patriti, A., Delrio, P., Scatizzi, M., Mancini, S., Garulli, G., Carrara, A., Pirozzi, F., et al. (2019). Colorectal surgery in Italy: A snapshot from the iCral study group. Updates in Surgery, 71, 515–524. https://doi.org/10.1007/s13304-018-00612-1

Carannante, F., Mascianà, G., Lauricella, S., Caricato, M., & Capolupo, G. T. (2019). Correction to: Skin bridge loop stoma: Outcome in 45 patients in comparison with stoma made on a plastic rod. International Journal of Colorectal Disease, 34(12), 2195–2197. https://doi.org/10.1007/s00384-019-03451-7

Herman Perroud | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Dr. Herman Perroud | Medicine and Dentistry | Best Researcher Award

Medical Oncology of Sanatorio de la mujer, Argentina

Dr. Herman Perroud is a distinguished MEDICAL ONCOLOGIST affiliated with SANATORIO DE LA MUJER, focusing on innovative research in BREAST CANCER and LUNG CANCER. His career is marked by leadership in the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and oversight of numerous clinical trials. With memberships in ASCO and ESMO, he contributes extensively to oncological advancements. Dr. Perroud’s contributions include publications in prominent journals, exploring new strategies like LOW DOSE CHEMOHERAPY for BREAST CANCER treatment. Recognized internationally for his scientific innovations, he continues to shape the field of oncology with dedication and expertise. 🌟🔬

Professional Profile:

 

Education🎓

Dr. Herman Perroud is a dedicated MEDICAL ONCOLOGIST at SANATORIO DE LA MUJER, focusing on BREAST CANCER and LUNG CANCER research. His academic endeavors include spearheading the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and contributing to clinical trials.

 

Professional Experience 📚

 

Dr. Herman Perroud, a distinguished Medical Oncologist affiliated with Sanatorio de la Mujer, brings extensive expertise in oncology and clinical research. With a robust career spanning years of dedicated service, he has contributed significantly to advancing cancer treatment methodologies, particularly in breast and lung cancers. Dr. Perroud leads multiple clinical trials, including an innovative Early Detection Program for Lung Cancer in Rosario, Argentina. His professional journey includes collaborations with international bodies like ASCO and ESMO, underscoring his commitment to global oncological advancements. Dr. Perroud’s impactful research, published in prestigious journals, focuses on early cancer detection and novel chemotherapy approaches for breast cancer treatment.

Research Interest 🔍

Dr. Herman Perroud’s research interests 🧬🔬 revolve around pioneering advancements in oncology, particularly focusing on breast and lung cancers. He is committed to exploring innovative methods for early cancer detection and refining therapeutic approaches, including low-dose chemotherapy. Dr. Perroud’s research aims to deepen the understanding of tumor biology and treatment modalities through rigorous clinical trials and collaborative studies. His work also encompasses investigating personalized medicine strategies and novel therapies to enhance treatment effectiveness and patient care in oncology.

Award and Honor🏆

Dr. Herman Perroud has received prestigious awards and honors in recognition of his contributions to medical oncology and research. His accolades underscore his dedication to advancing treatments for breast and lung cancers through innovative approaches. These awards highlight his significant impact on early detection methods for lung cancer in Rosario, Argentina, and his pioneering work in low-dose chemotherapy for breast cancer treatment. Dr. Perroud’s achievements are a testament to his leadership in the field, enhancing patient care and advancing scientific knowledge in oncology. 🏆🌟

Research Skills🌟

Dr. Herman Perroud is highly skilled in conducting cutting-edge research in the field of medical oncology, particularly focusing on breast cancer and lung cancer. His research skills encompass a wide range of methodologies, including clinical trials management and the implementation of innovative early detection programs. He demonstrates proficiency in data analysis, experimental design, and the application of advanced medical technologies to improve cancer diagnosis and treatment outcomes. Dr. Perroud’s contributions to the field reflect his deep commitment to advancing oncological research and translating scientific findings into impactful clinical practices, thereby significantly benefiting patients and the medical community alike.

Achievements🏅

  • Spearheaded the Early Detection Program of Lung Cancer in Rosario, Argentina.
  • Managed multiple clinical trials focusing on innovative treatments for breast cancer and lung cancer.
  • Published extensively in reputable journals on advancements in early cancer detection and low-dose chemotherapy.
  • Received international recognition and awards for contributions to oncological research.
  • Active member of prestigious organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology).
  • Established collaborations with prominent researchers and institutions globally.
  • Contributed significantly to the development of new methodologies in cancer research and treatment.
  • Recognized for leadership in integrating research findings into clinical practice to enhance patient care and outcomes.

Publications🏅

  • Book Chapter
    • Title: Protective effect of Vitamin A on male lung cancer
    • Authors: Dagatti, M.S., Compagnucci, A.B., Perroud, H.A., Pezzotto, S.M.
    • Book: Vitamin A: Nutrition, Side Effects and Supplements, 2021, pp. 193–210
  • Review Article
    • Title: Achievements and challenges in the use of metronomics for the treatment of breast cancer
    • Authors: Scharovsky, O.G., Rico, M.J., Mainetti, L.E., Perroud, H.A., Rozados, V.R.
    • Journal: Biochemical Pharmacology, 2020, 175, 113909
  • Article
    • Title: Correlation between predictors of coledocolithasis and findings of endoscopic retrograde cholangiopancreatography. From guidelines to practice | Correlación entre predictores de litiasis coledociana y los hallazgos en la colangiopancreatografía retrógrada endoscópica. De las guías a la práctica
    • Authors: Ripari, G., Wulfson, A., Guerrina, C., Perroud, H.
    • Journal: Acta Gastroenterologica Latinoamericana, 2017, 47(4), pp. 269–276
  • Article
    • Title: Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay
    • Authors: Rico, M.J., Perroud, H.A., Herrera, C., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2017, 35(6), pp. 377–385
  • Article
    • Title: The association between osteoporotic hip fractures and actinic lesions as a biomarker for cumulative sun exposure in older people—a retrospective case–control study in Argentina
    • Authors: Perroud, H.A., Dagatti, M.S., Amigot, B., Masoni, A.M., Pezzotto, S.M.
    • Journal: Journal of Bone and Mineral Metabolism, 2017, 35(3), pp. 324–329
  • Article
    • Title: Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Scharovsky, O.G., Rozados, V.R., Alasino, C.M.
    • Journal: ecancermedicalscience, 2017, 11, 723
  • Article
    • Title: A nested case-control study on dietary fat consumption and the risk for gallstone disease
    • Authors: Bertola Compagnucci, A., Perroud, H.A., Batallés, S.M., Berli, D., Pezzotto, S.M.
    • Journal: Journal of Human Nutrition and Dietetics, 2016, 29(3), pp. 338–344
  • Article
    • Title: Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Future Oncology, 2016, 12(10), pp. 1233–1242
  • Article
    • Title: Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: Clinical outcomes and biomarkers of response
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Chemotherapy and Pharmacology, 2016, 77(2), pp. 365–374
  • Article
    • Title: Comparative effectiveness of two metronomic chemotherapy schedules-our experience in the preclinical field
    • Authors: Rico, M.J., Perroud, H.A., Mainetti, L.E., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2014, 32(3), pp. 92–98